(Q43991024)

English

Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

0 references

author name string

Mark Palangio

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Donald W Northfelt

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Russell K Portenoy

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Daniel Brookoff

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ralph T Doyle

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Bruce E Dornseif

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Michael C Damask

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Journal of Pain and Symptom Management

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

355-368

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hydromorphone: pharmacology and clinical applications in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous infusions for control of cancer symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of orally administered sustained- release hydromorphone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analgesic efficacy and potency of two oral controlled-release morphine preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained blood pressure control with controlled-release isradipine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

More on the conversion of transdermal fentanyl to morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controversies in the long-term management of analgesic therapy in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of oral morphine for chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term oral opioid therapy in patients with chronic nonmalignant pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900390-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0885-3924(02)00390-1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43991024&oldid=2105375550"